HN1997000154A - Sales dimesilato de los ligandos del neuropeptido - Google Patents

Sales dimesilato de los ligandos del neuropeptido

Info

Publication number
HN1997000154A
HN1997000154A HN1997000154A HN1997000154A HN1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A
Authority
HN
Honduras
Prior art keywords
dimesylate
salts
neuropeptide ligands
neuropeptide
ligands
Prior art date
Application number
HN1997000154A
Other languages
English (en)
Spanish (es)
Inventor
Pfizer Products Inc
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1997000154A publication Critical patent/HN1997000154A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HN1997000154A 1996-11-26 1997-11-26 Sales dimesilato de los ligandos del neuropeptido HN1997000154A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
HN1997000154A true HN1997000154A (es) 1999-02-09

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000154A HN1997000154A (es) 1996-11-26 1997-11-26 Sales dimesilato de los ligandos del neuropeptido

Country Status (23)

Country Link
US (1) US5914329A (https=)
EP (1) EP0944611B1 (https=)
JP (1) JP3120861B2 (https=)
AP (1) AP9701148A0 (https=)
AR (1) AR010304A1 (https=)
AT (1) ATE257472T1 (https=)
AU (1) AU4792497A (https=)
BR (1) BR9713538A (https=)
CA (1) CA2272927C (https=)
DE (1) DE69727155T2 (https=)
DK (1) DK0944611T3 (https=)
ES (1) ES2213207T3 (https=)
GT (1) GT199700123A (https=)
HN (1) HN1997000154A (https=)
HR (1) HRP970640A2 (https=)
ID (1) ID18964A (https=)
MA (1) MA26450A1 (https=)
PA (1) PA8441701A1 (https=)
PE (1) PE17099A1 (https=)
PT (1) PT944611E (https=)
TN (1) TNSN97191A1 (https=)
WO (1) WO1998023603A1 (https=)
ZA (1) ZA9710587B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
WO2003049673A2 (en) 2001-12-05 2003-06-19 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
ATE321865T1 (de) 2002-01-09 2006-04-15 Arexis Ab Mutationsnachweis
ES2333739T3 (es) * 2004-11-23 2010-02-26 Dong Wha Pharmaceutical Co., Ltd. Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico.
WO2006108218A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014307A1 (en) * 1994-11-07 1996-05-17 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
JP3120861B2 (ja) 2000-12-25
EP0944611A1 (en) 1999-09-29
JP2000505110A (ja) 2000-04-25
MA26450A1 (fr) 2004-12-20
GT199700123A (es) 1999-05-19
ID18964A (id) 1998-05-28
PT944611E (pt) 2004-04-30
PA8441701A1 (es) 2000-05-24
DE69727155T2 (de) 2004-07-08
US5914329A (en) 1999-06-22
WO1998023603A1 (en) 1998-06-04
PE17099A1 (es) 1999-02-19
EP0944611B1 (en) 2004-01-07
DE69727155D1 (de) 2004-02-12
CA2272927C (en) 2003-02-04
DK0944611T3 (da) 2004-04-13
AU4792497A (en) 1998-06-22
BR9713538A (https=) 2000-03-21
TNSN97191A1 (fr) 2005-03-15
ZA9710587B (en) 1999-05-25
CA2272927A1 (en) 1998-06-04
ES2213207T3 (es) 2004-08-16
AP9701148A0 (en) 1998-01-31
HRP970640A2 (en) 1998-10-31
ATE257472T1 (de) 2004-01-15
AR010304A1 (es) 2000-06-07

Similar Documents

Publication Publication Date Title
HN1997000126A (es) Derivados de indazol
HN1997000090A (es) Compuestos de piridilpirrol
HN1998000175A (es) Imidazotriazininas
HN1998000132A (es) Combinaciones terapeuticas
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1997000099A (es) Inhibidores de metaloproteasas matriciales basados en
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1995009160A (es) Derivados de cicloalcano indol y azaindol
HN1997000149A (es) Derivados de 6 fenilpiridil 2 amina
HN1998000124A (es) Terapia de combinacion
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN1994000083A (es) Aparato de cierre
HN1997000079A (es) Analogos de indazol sustituido.
HN1997000083A (es) Derivados triciclicos sustituidos con fenilamino
HN1997000146A (es) Derivados de pirimidina biciclica condensada
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000118A (es) 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
HN1999000066A (es) Formulaciones farmaceuticas
HN1998000199A (es) Agentes terapeuticos
HN1998000045A (es) Composiciones farmaceuticas
HN1997000154A (es) Sales dimesilato de los ligandos del neuropeptido
HN1997000138A (es) Caramelo juguete
ES2169101T3 (es) Compuesto de metaloceno.